Regulators at some point stepped in. By 1984, the drug was stated as Schedule I in the US as well as a Class B drug in the united kingdom, that makes its generation and distribution illegal completely.one mutations on allopregnanolone-mediated potentiation in the GABAAR observed in this review are in concordance with those noted with the Good team,